![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 7, 4601-4604, February 15, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
From the
Laboratory for Developmental Neurobiology,
Brain Science Institute, RIKEN (The Institute of Physical and Chemical
Research), 2-1 Hirosawa, Wako, Saitama 351-0198, Japan, the
¶ Department of Biochemistry, University of Wisconsin, Madison,
Wisconsin 53706, and the
Division of Molecular Neurobiology,
Department of Basic Medical Science, The Institute of Medical Science,
The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
Received for publication, October 11, 2001, and in revised form, December 9, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Synaptotagmin (Syt) I-deficient phaeochromocytoma
(PC12) cell lines show normal
Ca2+-dependent norepinephrine (NE)
release (Shoji-Kasai, Y., Yoshida, A., Sato, K., Hoshino, T., Ogura,
A., Kondo, S., Fujimoto, Y., Kuwahara, R., Kato, R., and Takahashi, M. (1992) Science 256, 1821-1823). To identify an alternative
Ca2+ sensor, we searched for other Syt isoforms in Syt
I-deficient PC12 cells and identified Syt IX, an isoform closely
related to Syt I, as an abundantly expressed dense-core vesicle
protein. Here we show that Syt IX is required for the
Ca2+-dependent release of NE from PC12 cells.
Antibodies directed against the C2A domain of either Syt IX or Syt I
inhibited Ca2+-dependent NE release in
permeable PC12 cells indicating that both Syt proteins function in
dense-core vesicle exocytosis. Our results support the idea that Syt
family proteins that co-reside on secretory vesicles may function
cooperatively and redundantly as potential Ca2+ sensors for exocytosis.
Neurotransmitter release is achieved by fusion of synaptic
vesicles to presynaptic plasma membranes (i.e. exocytosis)
in response to a rapid increase in Ca2+ ions entering
through voltage-gated Ca2+ channels.
Ca2+-binding proteins (so-called "Ca2+
sensors") (for reviews, see Refs. 1 and 2) must be present on the
synaptic vesicles to sense such rapid increases in Ca2+
ions. Genetic and biochemical evidence during the past decade indicates
that synaptotagmin I (Syt
I),1 a
Ca2+-binding protein abundant in synaptic vesicles, is the
most likely candidate for the major Ca2+ sensor for
neurotransmitter release in the central nervous system (Ref. 3 and
reviewed in Refs. 4-6). Syt I contains one transmembrane region at the
amino terminus and two C2 domains (the C2A domain and C2B domain) in
the cytoplasmic domain, and Ca2+ binding to the C2A domain
is essential for regulating Ca2+-dependent
neurotransmitter release (3). Syt I is also found in the secretory
granules of some endocrine cells (e.g. chromaffin cells,
pancreatic In this study we show that Syt IX is a major Syt isoform that is
abundantly expressed on dense-core vesicles and regulates Ca2+-dependent secretion in PC12 cells. Based
on our finding, we discuss the functional relationship between Syt I
and Syt IX in PC12 cells.
Antibody Purification--
The anti-Syt I mouse monoclonal
antibody (Ab) (SYA148) was from StressGen. The anti-Syt I-C2A rabbit Ab
was prepared as described previously (17, 18). New Zealand White
rabbits were immunized with the purified glutathione
S-transferase (GST)-Syt IX-C2A (19), and the anti-Syt IX-C2A
Ab was affinity-purified by exposure to antigen bound to Affi-Gel 10 beads (Bio-Rad) as described previously (17, 20). The cross-reactive
component to Syt I was removed by incubation with glutathione-Sepharose
(Amersham Biosciences, Inc.) coupled to 1 mg of GST-Syt I-C2A proteins
(20). The Abs specific for the amino-terminal domain of mouse Syt I
(anti-Syt I-N) and Syt IX (anti-Syt IX-N) were raised against the
following synthetic peptides: MVSASRPEALAAPVTTVATC (Syt I-N) and
KTPPDSSRIRQGAVC (Syt IX-N). The Abs were affinity-purified by exposure
to antigenic peptide bound to FMP-activated Cellulofine
(Seikagaku Co.) as described previously (21). Specificity of these
antibodies was checked by immunoblotting using recombinant T7-tagged
Syts I-XIII expressed in COS-7 cells (22-24). Under our experimental
conditions, we could not observe cross-reactivity of anti-Syt IX-C2A
and anti-Syt IX-N Abs with Syt I in immunoblotting. The protein
concentration was determined with a Bio-Rad protein assay kit
using bovine serum albumin as a reference. Immunoblotting was
performed as described previously (20, 23).
Antibody Uptake Experiments--
The purified anti-Syt I-N and
anti-Syt IX-N Abs were conjugated with
5-(and-6)-carboxytetramethylrhodamine (Molecular Probes catalog no.
C-1171) and 5-carboxyfluorescein (Molecular Probes catalog no.
C-2210), respectively, according to the instructions of the
manufacturer (17, 25). Nerve growth factor-differentiated PC12 cells
were cultured on 35-mm glass-bottom dishes coated with collagen type IV
(MaTek Corp.) in Dulbecco's modified Eagle's medium containing 10%
horse serum and 10% fetal bovine serum at 37 °C under 5%
CO2. After washing twice with phosphate-buffered saline,
the cells were stimulated for 10 min at 37 °C with either low KCl
buffer (5.6 mM KCl, 145 mM NaCl, 2.2 mM CaCl2, 0.5 mM MgCl2,
5.6 mM glucose, and 15 mM HEPES-KOH, pH 7.4) or
high KCl buffer (56 mM KCl, 95 mM NaCl, 2.2 mM CaCl2, 0.5 mM MgCl2,
5.6 mM glucose, and 15 mM HEPES-KOH, pH 7.4)
containing rhodamine-labeled anti-Syt I-N Ab (1 µg/ml) and
fluorescein-labeled anti-Syt I Ab (10 µg/ml). The cells were
immediately washed twice with phosphate-buffered saline and then fixed
in 4% paraformaldehyde in 0.1 M sodium phosphate buffer
for 20 min at room temperature as described previously (20, 22).
Incorporated antibodies were analyzed with a fluorescence microscope
(TE300, Nikon) attached to a laser confocal scanner unit CSU 10 (Yokogawa Electric Corp.) and HiSCA CCD camera (C6790, Hamamatsu
Photonics). Images were pseudo-colored and superimposed with Adobe
Photoshop software (Version 4.0) (20, 22).
Assays for Ca2+-activated Exocytosis--
Assays of
the Ca2+-triggered release of [3H]NE from
permeable PC12 cells were conducted as described previously (26). PC12 cells, cultured as described previously (27), were incubated with 0.5 µC/ml [3H]NE (Amersham Biosciences, Inc.) and 0.5 mM ascorbate for 16 h at 37 °C. Cells were washed,
preincubated in culture medium for two 1-h incubations, and removed
from dishes by pipetting with ice-cold KGlu buffer (20 mM
HEPES, pH 7.2, 120 mM potassium glutamate (KGlu), 20 mM potassium acetate, 2 mM EGTA, and 0.1% bovine serum albumin). Cells were permeabilized by a single passage through a stainless steel ball homogenizer (28) and preincubated with
KGlu buffer adjusted to 11 mM EGTA for 1 h on ice.
Permeable cells were primed in incubations for 30 min at 30 °C in
KGlu buffer containing 2 mM MgATP plus 1 mg/ml rat brain
cytosol. Following two washes, the permeable cells were preincubated
with antibodies where indicated for 1 h on ice and incubated at
30 °C for 3 min in triggering reactions containing KGlu buffer with
free Ca2+ adjusted to 1 mM plus 0.1 mg/ml rat
brain cytosol. Reactions were terminated by chilling followed by
sedimentation at 2,000 × g for 10 min.
[3H]NE in the supernatants and the 1% Triton
X-100-solubilized cell pellets were used to calculate
Ca2+-dependent [3H]NE release as
a percentage of total [3H]NE in each incubation.
Miscellaneous Procedures--
SDS-polyacrylamide gel
electrophoresis and immunoblotting analyses were performed as described
previously (23). Immunostaining of Syts I and IX in PC12 cells was also
performed as described previously (20, 22). Preparation of GST fusion
proteins and the phosphatidylserine/phosphatidylcholine (PS/PC; 1:1,
w/w) (or PC) liposome binding assay were also carried out as described elsewhere (19, 29). Syt I-deficient PC12 cells were isolated as a
G418-resistant cell line following transfection with a pcDNA3.1 plasmid containing a rat Syt I cDNA sequence ( Synaptotagmin has been found to represent a large protein family
in both vertebrates and invertebrates, and 13 isoforms have been
identified in the rat and mouse (4, 23, 24) (Fig. 1C). Since several other
presynaptic proteins show functional redundancy in the brain
(e.g. synapsins, complexins, and SV2s) (30-32), we
hypothesized that other Syt isoforms may compensate for the function of
Syt I in the Syt I-deficient PC12 cells. To test this hypothesis, we
generated a specific antibody against each Syt isoform (Syts
I-XIII)2 and examined its
expression in normal and Syt I-deficient PC12 cell lines (PC12-a and
-b). Quantitative analysis by using the recombinant Syts I-XIII with a
T7 tag indicated that only the Syt IX isoform (formally called Syt V)
(33, 34)2 is expressed as abundantly as the Syt I isoform
in both PC12 cell lines but that it is less abundant in brain (Fig. 1,
A and B). The most important finding was that the
Syt I expression level is dramatically reduced in PC12-b cells (less
than 5% of that of normal PC12-a cells) and that the Syt IX expression
level is significantly higher than that of normal PC12 cells (Fig.
1B), suggesting that Syt IX may substitute for Syt I
function in PC12-b cells. Consistent with this hypothesis, the
phylogenetic distance between invertebrate Syt I and mouse Syt IX is
indistinguishable from that between invertebrate Syt I and mouse Syt I
(Fig. 1C, boxed), and the
Ca2+-dependent phospholipid binding properties
of Syts I, II, and IX are the same in terms of affinity for
Ca2+ and specificity for phospholipids (19, 29). The C2A
domain of Syt IX fused to GST bound PS/PC liposomes in a
Ca2+-dependent manner but did not bind PC
liposomes alone, irrespective of the presence of Ca2+ (Fig.
1D).
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-cell lines, and PC12 cells) and has been shown to be
involved in Ca2+-dependent endocrine exocytosis
by peptide or antibody injection experiments (7-10), suggesting a role
of Syt I as an endocrine Ca2+ sensor (11). However, in
1992, Syt I-deficient PC12 cell lines exhibiting normal
Ca2+-dependent norepinephrine (NE) release were
established (12). Their existence strongly contradicts the notion that
Syt I is the major Ca2+ sensor for endocrine exocytosis
(12), and the presence of an alternate Ca2+ sensor for Syt
I in PC12 cells has been proposed (e.g. rabphilin, Doc2,
calmodulin, and frequenin) (13-16). However, the actual alternative Ca2+ sensor to Syt I in PC12 cells has not yet been identified.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
22 to 109) in
reverse orientation. Immunoblotting indicated the complete absence of Syt I protein but normal levels of Syt IX, syntaxin 1A, VAMP2, and
SNAP-25.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (37K):
[in a new window]
Fig. 1.
Expression of Syt IX, a closely related
isoform of Syt I, in PC12 cells. A, expression of Syts
I, II, and IX in normal and Syt I-deficient PC12 cell lines (PC12-a and
PC12-b cells, respectively). The same amount of recombinant T7-tagged
Syt I, II, or IX expressed in COS-7 cells (lanes 1-3),
total homogenates of two PC12 cell lines (20 µg; lanes 4 and 5), and of adult mouse brain (20 µg; lane 6) were
loaded on 10% SDS-polyacrylamide gel and immunoblotted with anti-T7
(bottom panel) or anti-Syt I, II, or IX specific antibody. The
specificity of each antibody was confirmed by using recombinant T7-Syts
I, II, and IX expressed in COS-7 cells (lanes 1-3). The
positions of the molecular weight markers (× 10
3) are
shown at the right. B, relative amounts of Syt I (open bars)
and Syt IX (closed bars). Immunoreactive bands in A were
captured by Gel Print 2000i/VGA and analyzed with Basic Quantifier
Software (Bio Image). The intensities of Syt I and Syt IX in PC12 cells
were calibrated by T7-tagged recombinant proteins (bottom panel in
A). C, phylogenetic analysis of mouse Syts I-XIII
and invertebrate Syt I by the CLUSTALW program (24). D,
Ca2+-dependent phospholipid (PS/PC or PC
liposome) binding activity of the C2A domain of Syt II and Syt IX fused
to GST as previously described (19, 29). Open bars indicate
phospholipid binding in the presence of 2 mM EGTA, and
closed bars, in the presence of 1 mM Ca2+.
C. elegans, Caenorhabditis
elegans.
If Syt IX compensates for the function of Syt I in Syt I-deficient PC12
cells, the Syt IX would be expected to be localized to dense-core
vesicles. Immunocytochemical studies indicated that Syt IX was present
at the tips of neurites where dense-core vesicles are enriched, and it
closely co-localized with Syt I (Fig. 2, Syt IX in green (A), Syt I in red
(B), and overlay in yellow (C)). The
specificity of the anti-Syt IX antibody was confirmed by incubation with antigenic peptide (Fig. 2, D and E). To
examine the dynamics of Syt IX molecules during
Ca2+-dependent exocytosis, Abs directed against
the luminal domain of Syt IX conjugated to fluorescein and the luminal
domain of Syt I conjugated to rhodamine were added to the culture
medium (24, 35), and the cells were stimulated with a low or high concentration of KCl. Uptake of both the fluorescein-Syt IX Ab and
rhodamine-Syt I Ab into neurites and cell body occurred only at
depolarizing KCl concentrations (Fig. 3,
A-D and G-J). Co-localization of the
fluorescein-Syt IX Ab and the rhodamine-Syt I Ab (Fig. 3,
C and I, arrowheads) indicated that
Syt I and IX proteins are present on the same vesicles that undergo
Ca2+-dependent exocytosis.
|
|
We had previously shown that inhibition of Ca2+/phospholipid binding to the C2A domain of Syt I by anti-Syt I-C2A Ab blocks neurotransmitter release in the squid giant synapse and superior cervical ganglion neurons (17, 18). Because the role of Syts in Ca2+-dependent exocytosis in PC12 cells is unclear (12), we introduced Syt C2A antibodies into permeabilized PC12 cells (26-28) to assess their effect on Ca2+-dependent NE release. The Ab against the C2A domain of Syt IX (anti-Syt IX-C2A) inhibited Ca2+-dependent NE release in a dose-dependent manner with maximal inhibition at about 50% (Fig. 3K, left, circles), whereas a preimmune Ab did not have any significant effect (Fig. 3K, left, squares). Similar results were obtained when the anti-Syt I-C2A Ab was introduced into permeable PC12 cells with maximal inhibition at about 50% (Fig. 3K, left, triangles). To analyze the functional relationship between Syts I and IX in NE release, the anti-Syt I-C2A and anti-Syt IX-C2A Abs were simultaneously introduced into PC12 cells. No significant additive effect of these two antibodies was observed at maximally effective concentrations of both antibodies (Fig. 3K, middle).
To assess whether antibody inhibition could result from steric effects or cross-linking of bivalent IgGs, we tested Fab fragments of the Abs. Fab fragments from either the Syt IX-C2A or the Syt I-C2A Ab strongly inhibited Ca2+-dependent NE release from wild type PC12 cells with maximal inhibition exceeding 80% (Fig. 3K, right, open symbols). As anticipated, the Syt I-C2A Fab fragments failed to inhibit Ca2+-dependent NE release from Syt I-deficient PC12 cells, whereas the Syt IX-C2A Fab fragments were fully inhibitory (Fig. 3K, right, closed symbols). The greater inhibitory effect of the Fab fragments compared with IgGs suggests that full access of larger IgGs to the C2A domain may be limited, which could be due to C2A domain-protein interactions that may be important for transmitter secretion (for a review, see Ref. 4). Alternatively, cross-linking of Syt I or IX isoforms by bivalent IgGs may allow residual Syt function in NE release. The results for Fab fragments indicate that inhibition of either Syt I or Syt IX in wild type PC12 cells is sufficient to block Ca2+-dependent exocytosis. This suggests that Syts I and IX function interdependently, which is consistent with our finding that both reside on the same vesicles and with our previous studies showing that Syts I and IX can form Ca2+-dependent hetero-oligomers (36).
In summary, several lines of evidence indicate that Syt IX is a major
Syt isoform that is required for Ca2+-dependent
secretion in PC12 cells. First, in wild type PC12 cells, Syt IX is
expressed as abundantly as Syt I, and in Syt I-deficient PC12 cells,
the expression of Syt IX is up-regulated (Fig. 1). No other Syt
isoforms including Syt VII, a recently proposed plasma membrane
Ca2+ sensor (37), are expressed abundantly (although Syt
IV, a third isoform expressed in PC12 cells, is present at <5% of the
level of Syt I). Second, both Syt I and Syt IX are present on the same vesicles that undergo Ca2+-dependent exocytosis
(Figs. 2 and 3). Third, the Ca2+-dependent
binding of the Syt IX C2A domain to phospholipids (Fig. 1) is similar
to that of the Syt I C2A domain (19, 29), and similar
Ca2+-dependent interactions of Syt I (38) and
Syt IX with SNAP-25 have been characterized.2 Last, Fab
fragments from either Syt I-C2A or Syt IX-C2A Abs almost completely
inhibited Ca2+-dependent NE release in PC12
cells (Fig. 3). Based on these results, we propose that PC12 cells
utilize two Ca2+ sensors, Syts I and IX, on the same
vesicles that function cooperatively to mediate the Ca2+
triggering of exocytosis. This hypothesis can account for the finding
that Syt I-deficient PC12 cells exhibit normal
Ca2+-dependent NE release; Syt IX can function
as an alternate Ca2+ sensor.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Eiko Kanno and Yukie Ogata for technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported in part by grants from the Science and Technology Agency to Japan (to K. M.), Grant 13780624 from the Ministry of Education, Science, and Culture of Japan (to M. F.), and National Institutes of Health Grant DK25861 (to T. F. J. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. Tel.: 81-48-467-9745; Fax: 81-48-467-9744; E-mail: mnfukuda@brain.riken.go.jp.
Published, JBC Papers in Press, December 21, 2001, DOI 10.1074/jbc.C100588200
2 X. Zhang, M. J. Kim-Miller, M. Fukuda, J. A. Kowalchyck, and T. F. J. Martin, submitted for publication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: Syt, synaptotagmin; Ab, antibody; GST, glutathione S-transferase; NE, norepinephrine; PC, phosphatidylcholine; PS, phosphatidylserine.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bennett, M. R. (1999) Prog. Neurobiol. 59, 243-277 |
| 2. | Augustine, G. J. (2001) Curr. Opin. Neurobiol. 11, 320-326 |
| 3. | Fernandez-Chacon, R., Konigstorfer, A., Gerber, S. H., Garcia, J., Matos, M. F., Stevens, C. F., Brose, N., Rizo, J., Rosenmund, C., and Südhof, T. C. (2001) Nature 410, 41-49 |
| 4. | Marquèze, B., Berton, F., and Seagar, M. (2000) Biochimie (Paris) 82, 409-420 |
| 5. | Schiavo, G., Osborne, S. L., and Sgouros, J. G. (1998) Biochem. Biophys. Res. Commun. 248, 1-8 |
| 6. | Fukuda, M., and Mikoshiba, K. (1997) Bioessays 19, 593-603 |
| 7. | Elferink, L. A., Peterson, M. R., and Scheller, R. H. (1993) Cell 72, 153-159 |
| 8. | Lang, J., Fukuda, M., Zhang, H., Mikoshiba, K., and Wollheim, C. B. (1997) EMBO J. 16, 5837-5846 |
| 9. | Ohara-Imaizumi, M., Fukuda, M., Niinobe, M., Misonou, H., Ikeda, K., Murakami, T., Kawasaki, M., Mikoshiba, K., and Kumakura, K. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 287-291 |
| 10. | Desai, R. C., Vyas, B., Earles, C. A., Littleton, J. T., Kowalchyck, J. A., Martin, T. F. J., and Chapman, E. R. (2000) J. Cell Biol. 150, 1125-1136 |
| 11. | Martin, T. F. J. (1994) Curr. Opin. Neurobiol. 4, 626-632 |
| 12. | Shoji-Kasai, Y., Yoshida, A., Sato, K., Hoshino, T., Ogura, A., Kondo, S., Fujimoto, Y., Kuwahara, R., Kato, R., and Takahashi, M. (1992) Science 256, 1821-1823 |
| 13. | Weiss, J. L., Archer, D. A., and Burgoyne, R. D. (2000) J. Biol. Chem. 275, 40082-40087 |
| 14. | Chung, S. H., Takai, Y., and Holz, R. W. (1995) J. Biol. Chem. 270, 16714-16718 |
| 15. | Orita, S., Sasaki, T., Komuro, R., Sakaguchi, G., Maeda, M., Igarashi, H., and Takai, Y. (1996) J. Biol. Chem. 271, 7257-7260 |
| 16. | Chen, Y. A., Duvvuri, V., Schulman, H., and Scheller, R. H. (1999) J. Biol. Chem. 274, 26469-26476 |
| 17. | Mikoshiba, K., Fukuda, M., Moreira, J. E., Lewis, F. M. T., Sugimori, M., Niinobe, M., and Llinás, R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10703-10707 |
| 18. | Mochida, S., Fukuda, M., Niinobe, M., Kobayashi, H., and Mikoshiba, K. (1997) Neuroscience 77, 937-943 |
| 19. | Fukuda, M., Kojima, T., and Mikoshiba, K. (1996) J. Biol. Chem. 271, 8430-8434 |
| 20. | Fukuda, M., and Mikoshiba, K. (1999) J. Biol. Chem. 274, 31428-31434 |
| 21. | Kida, Y., Sakaguchi, M., Fukuda, M., Mikoshiba, K., and Mihara, K. (2000) J. Cell Biol. 150, 719-730 |
| 22. | Ibata, K., Fukuda, M., Hamada, T., Kabayama, H., and Mikoshiba, K. (2000) J. Neurochem. 74, 518-526 |
| 23. | Fukuda, M., Kanno, E., and Mikoshiba, K. (1999) J. Biol. Chem. 274, 31421-31427 |
| 24. | Fukuda, M., and Mikoshiba, K. (2001) Biochem. J. 354, 249-257 |
| 25. | Sugimori, M., Tong, C.-K., Fukuda, M., Moreira, J. E., Kojima, T., Mikoshiba, K., and Llinás, R. (1998) Neuroscience 86, 39-51 |
| 26. | Hay, J. C., and Martin, T. F. J. (1992) J. Cell Biol. 119, 139-151 |
| 27. | Lomneth, R., Martin, T. F. J., and DasGupta, B. R. (1991) J. Neurochem. 57, 1413-1421 |
| 28. | Martin, T. F. J. (1989) Methods Enzymol. 168, 225-233 |
| 29. | Fukuda, M., Kojima, T., and Mikoshiba, K. (1997) Biochem. J. 323, 421-425 |
| 30. | Reim, K., Mansour, M., Varoqueaux, F., McMahon, H. T., Südhof, T. C., Brose, N., and Rosenmund, C. (2001) Cell 104, 71-81 |
| 31. | Janz, R., Goda, Y., Geppert, M., Missler, M., and Südhof, T. C. (1999) Neuron 24, 1003-1016 |
| 32. | Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., and Südhof, T. C. (1995) Nature 375, 488-493 |
| 33. | Craxton, M., and Goedert, M. (1995) FEBS Lett. 361, 196-200 |
| 34. | Hudson, A. W., and Birnbaum, M. J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5895-5899 |
| 35. | Kraszewski, K., Mundigl, O., Daniell, L., Verderio, C., Matteoli, M., and De Camilli, P. (1995) J. Neurosci. 15, 4328-4342 |
| 36. | Fukuda, M., and Mikoshiba, K. (2000) J. Biochem. (Tokyo) 128, 637-645 |
| 37. | Sugita, S., Han, W., Butz, S., Liu, X., Fernandez-Chacon, R., Lao, Y., and Südhof, T. C. (2001) Neuron 30, 459-473 |
| 38. | Gerona, R. R., Larsen, E. C., Kowalchyk, J. A., and Martin, T. F. J. (2000) J. Biol. Chem. 275, 6328-6336 |
This article has been cited by other articles:
![]() |
W. H. Roden, J. B. Papke, J. M. Moore, A. L. Cahill, H. Macarthur, and A. B. Harkins Stable RNA interference of synaptotagmin I in PC12 cells results in differential regulation of transmitter release Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1742 - C1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuboi and M. Fukuda Synaptotagmin VII modulates the kinetics of dense-core vesicle exocytosis in PC12 cells Genes Cells, April 1, 2007; 12(4): 511 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Lynch and T. F. J. Martin Synaptotagmins I and IX function redundantly in regulated exocytosis but not endocytosis in PC12 cells J. Cell Sci., February 15, 2007; 120(4): 617 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Moore, J. B. Papke, A. L. Cahill, and A. B. Harkins Stable gene silencing of synaptotagmin I in rat PC12 cells inhibits Ca2+-evoked release of catecholamine Am J Physiol Cell Physiol, August 1, 2006; 291(2): C270 - C281. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nagy, J. H. Kim, Z. P. Pang, U. Matti, J. Rettig, T. C. Sudhof, and J. B. Sorensen Different Effects on Fast Exocytosis Induced by Synaptotagmin 1 and 2 Isoforms and Abundance But Not by Phosphorylation J. Neurosci., January 11, 2006; 26(2): 632 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wang, M. C. Chicka, A. Bhalla, D. A. Richards, and E. R. Chapman Synaptotagmin VII Is Targeted to Secretory Organelles in PC12 Cells, Where It Functions as a High-Affinity Calcium Sensor Mol. Cell. Biol., October 1, 2005; 25(19): 8693 - 8702. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bhalla, W. C. Tucker, and E. R. Chapman Synaptotagmin Isoforms Couple Distinct Ranges of Ca2+, Ba2+, and Sr2+ Concentration to SNARE-mediated Membrane Fusion Mol. Biol. Cell, October 1, 2005; 16(10): 4755 - 4764. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Haberman, I. Ziv, Y. Gorzalczany, M. Fukuda, and R. Sagi-Eisenberg Classical protein kinase C(s) regulates targeting of synaptotagmin IX to the endocytic recycling compartment J. Cell Sci., April 15, 2005; 118(8): 1641 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Atiya-Nasagi, H. Cohen, O. Medalia, M. Fukudan, and R. Sagi-Eisenberg O-glycosylation is essential for intracellular targeting of synaptotagmins I and II in non-neuronal specialized secretory cells J. Cell Sci., April 1, 2005; 118(7): 1363 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda, E. Kanno, M. Satoh, C. Saegusa, and A. Yamamoto Synaptotagmin VII Is Targeted to Dense-core Vesicles and Regulates Their Ca2+-dependent Exocytosis in PC12 Cells J. Biol. Chem., December 10, 2004; 279(50): 52677 - 52684. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda and A. Yamamoto Effect of Forskolin on Synaptotagmin IV Protein Trafficking in PC12 Cells J. Biochem., August 1, 2004; 136(2): 245 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iezzi, G. Kouri, M. Fukuda, and C. B. Wollheim Synaptotagmin V and IX isoforms control Ca2+-dependent insulin exocytosis J. Cell Sci., July 1, 2004; 117(15): 3119 - 3127. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Morenilla-Palao, R. Planells-Cases, N. Garcia-Sanz, and A. Ferrer-Montiel Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity J. Biol. Chem., June 11, 2004; 279(24): 25665 - 25672. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Imai, S. Yoshie, T. Nashida, H. Shimomura, and M. Fukuda The small GTPase Rab27B regulates amylase release from rat parotid acinar cells J. Cell Sci., April 15, 2004; 117(10): 1945 - 1953. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rickman, D. A. Archer, F. A. Meunier, M. Craxton, M. Fukuda, R. D. Burgoyne, and B. Davletov Synaptotagmin Interaction with the Syntaxin/SNAP-25 Dimer Is Mediated by an Evolutionarily Conserved Motif and Is Sensitive to Inositol Hexakisphosphate J. Biol. Chem., March 26, 2004; 279(13): 12574 - 12579. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda, E. Kanno, and A. Yamamoto Rabphilin and Noc2 Are Recruited to Dense-core Vesicles through Specific Interaction with Rab27A in PC12 Cells J. Biol. Chem., March 26, 2004; 279(13): 13065 - 13075. [Abstract] [Full Text] [PDF] |
||||
![]() |
O.-H. Shin, A. Maximov, B. K. Lim, J. Rizo, and T. C. Sudhof Unexpected Ca2+-binding properties of synaptotagmin 9 PNAS, February 24, 2004; 101(8): 2554 - 2559. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sadakata, A. Mizoguchi, Y. Sato, R. Katoh-Semba, M. Fukuda, K. Mikoshiba, and T. Furuichi The Secretory Granule-Associated Protein CAPS2 Regulates Neurotrophin Release and Cell Survival J. Neurosci., January 7, 2004; 24(1): 43 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wang, C.-T. Wang, J. Bai, M. B. Jackson, and E. R. Chapman Mutations in the Effector Binding Loops in the C2A and C2B Domains of Synaptotagmin I Disrupt Exocytosis in a Nonadditive Manner J. Biol. Chem., November 21, 2003; 278(47): 47030 - 47037. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Haberman, E. Grimberg, M. Fukuda, and R. Sagi-Eisenberg Synaptotagmin IX, a possible linker between the perinuclear endocytic recycling compartment and the microtubules J. Cell Sci., November 1, 2003; 116(21): 4307 - 4318. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dong, D. A. Richards, M. C. Goodnough, W. H. Tepp, E. A. Johnson, and E. R. Chapman Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells J. Cell Biol., September 29, 2003; 162(7): 1293 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Sorensen, R. Fernandez-Chacon, T. C. Sudhof, and E. Neher Examining Synaptotagmin 1 Function in Dense Core Vesicle Exocytosis under Direct Control of Ca2+ J. Gen. Physiol., August 25, 2003; 122(3): 265 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Tucker, J. M. Edwardson, J. Bai, H.-J. Kim, T. F.J. Martin, and E. R. Chapman Identification of synaptotagmin effectors via acute inhibition of secretion from cracked PC12 cells J. Cell Biol., July 21, 2003; 162(2): 199 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda Molecular Cloning, Expression, and Characterization of a Novel Class of Synaptotagmin (Syt XIV) Conserved from Drosophila to Humans J. Biochem., May 1, 2003; 133(5): 641 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda, E. Kanno, Y. Ogata, C. Saegusa, T. Kim, Y. P. Loh, and A. Yamamoto Nerve Growth Factor-dependent Sorting of Synaptotagmin IV Protein to Mature Dense-core Vesicles That Undergo Calcium-dependent Exocytosis in PC12 Cells J. Biol. Chem., January 24, 2003; 278(5): 3220 - 3226. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda and T. S. Kuroda Slac2-c (Synaptotagmin-like Protein Homologue Lacking C2 Domains-c), a Novel Linker Protein that Interacts with Rab27, Myosin Va/VIIa, and Actin J. Biol. Chem., November 1, 2002; 277(45): 43096 - 43103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda, E. Kanno, C. Saegusa, Y. Ogata, and T. S. Kuroda Slp4-a/Granuphilin-a Regulates Dense-core Vesicle Exocytosis in PC12 Cells J. Biol. Chem., October 11, 2002; 277(42): 39673 - 39678. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda Vesicle-associated Membrane Protein-2/Synaptobrevin Binding to Synaptotagmin I Promotes O-Glycosylation of Synaptotagmin I J. Biol. Chem., August 9, 2002; 277(33): 30351 - 30358. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Saegusa, M. Fukuda, and K. Mikoshiba Synaptotagmin V Is Targeted to Dense-core Vesicles That Undergo Calcium-dependent Exocytosis in PC12 Cells J. Biol. Chem., June 28, 2002; 277(27): 24499 - 24505. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda, T. S. Kuroda, and K. Mikoshiba Slac2-a/Melanophilin, the Missing Link between Rab27 and Myosin Va. IMPLICATIONS OF A TRIPARTITE PROTEIN COMPLEX FOR MELANOSOME TRANSPORT J. Biol. Chem., March 29, 2002; 277(14): 12432 - 12436. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||